During the first half of 2025, QDII funds witnessed an average increase in net value of 13.19%. Notably, funds specifically targeting the innovative medicine sector in Hong Kong stocks shone brightly, with multiple funds achieving a year-on-year net value growth of over 40%, showcasing exceptional performance. Additionally, European-focused and gold-themed QDII funds also recorded impressive gains, surpassing 20%.